ArticleThoracic cancer2021

Clinical utility of the C-reactive protein:albumin ratio in non-small cell lung cancer patients treated with nivolumab.

Taisuke Araki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.